Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2010
11/04/2010WO2010125069A1 Hyaluronic acid for preventing post surgical adhesions
11/04/2010WO2010125042A1 Isoxazole derivatives
11/04/2010WO2010125033A1 Azabicyclo[4.1.0]heptane derivatives
11/04/2010WO2010125004A1 Cdk inhibitor salts
11/04/2010WO2010124874A1 Hepcidin binding nucleic acids
11/04/2010WO2010124873A1 3- (2, 2, 2, trimethylhydrazunium) propionate dihydrate (meldomium) for treating parkinson' s disease
11/04/2010WO2010124856A1 Use of 1-phenyl-3-dimethylaminopropane compounds for treating rheumatoid pain
11/04/2010WO2010124847A1 Combination therapy comprising mechanical vibration for the treatment of a disease of the musculoskeletal or nervous system
11/04/2010WO2010124845A1 Pesticidal arylpyrrolidines
11/04/2010WO2010124826A1 Substituted imidazoquinoxalines
11/04/2010WO2010124713A1 Quinone derivative 2,3-dimethoxy-5-methyl-6-(10-hydroxydecyl)-1,4-benzoquinone for the treatment of primary progressive multiple sclerosis
11/04/2010WO2010124695A1 Use of griseofulvin for the improvement of mental faculties: attention, concentration and memory
11/04/2010WO2010124654A1 Vascular embolus of sodium alginate microspheres comprising drug for resisting hemangioma, preparation method, and use thereof
11/04/2010WO2010124648A1 Azaazulene compounds
11/04/2010WO2010124623A1 Medicine for preventing and treating alzheimer's disease and preparative method thereof
11/04/2010WO2010124618A1 Use of cell autophagy (type ii cell apoptosis) inhibitors
11/04/2010WO2010124601A1 Method for producing injectable preparation containing ceftriaxone sodium and tazobactam sodium
11/04/2010WO2010124540A1 Flexible liposome of resveratrol and preparation method thereof
11/04/2010WO2010124525A1 Self micro-emulsifying oral pharmaceutical composition of hydrophilic drug and preparation method thereof
11/04/2010WO2010124522A1 Arsenic compounds, their preparation methods and uses thereof
11/04/2010WO2010124521A1 Derivatives of rhein, preparation methods and uses thereof
11/04/2010WO2010124520A1 Pharmaceutical composition for treating abnormal energy metabolism and use thereof
11/04/2010WO2010124428A1 A stabilizer for preparing freeze-dried vaccine without gelatin and the preparation method of freeze-dried vaccine
11/04/2010WO2010124392A1 Methods, compositions, and kits for the treatment of inflammatory conditions
11/04/2010WO2010124391A1 Methods and compositions for improving the health of animals
11/04/2010WO2010124385A1 Processes for the preparation of rivaroxaban and intermediates thereof
11/04/2010WO2010103362A3 Process for the preparation of bosentan
11/04/2010WO2010103273A3 Essential fatty acid compounds
11/04/2010WO2010102248A3 Molecular tweezers for the treatment of amyloid-related diseases
11/04/2010WO2010101485A3 A pharmaceutical composition containing celecoxib and a process of the manufacture thereof
11/04/2010WO2010095943A3 Use of resveratrol or another hydroxylated stilbene for preserving cognitive functioning
11/04/2010WO2010095144A3 Process for preparation of proton pump inhibitors
11/04/2010WO2010092190A3 Prediction of response to platinum-based therapy
11/04/2010WO2010089768A3 Bortezumib containing pharmaceutical composition
11/04/2010WO2010085811A9 Use of pterosin compounds for treating diabetes and obesity
11/04/2010WO2010085797A3 Arginase inhibitors and methods of use
11/04/2010WO2010085352A3 Bumetanide, furosemide, piretanide, azosemide, and torsemide analogs, compositions and methods of use
11/04/2010WO2010085047A3 Solid pharmaceutical composition comprising amlodipine and losartan
11/04/2010WO2010083404A3 Linked myc-max small molecule inhibitors
11/04/2010WO2010083240A9 Methods for treating inflammatory disorders using 2,4-pyrimidinediamine compounds
11/04/2010WO2010083215A3 Composition and method for the treatment of diseases affected by apoptosis
11/04/2010WO2010083207A3 Protein kinase c inhibitors and uses thereof
11/04/2010WO2010083035A3 Transdermal administration of tamsulosin
11/04/2010WO2010082858A3 New method for obtaining 5-amino-2,3-dihydrophthalazine-1,4-dione alkali metal salts and their use in medicine
11/04/2010WO2010082219A3 An arteether injection for treatment of malaria
11/04/2010WO2010081032A3 Steroidal compositions
11/04/2010WO2010080769A3 Chemotherapeutic methods and compositions
11/04/2010WO2010080414A3 Substituted fno (2-[furan-2-yl] naphthalen-1-ol) derivatives as anti-cancer agents
11/04/2010WO2010078419A3 Herbal-based nasal solution and method of use thereof
11/04/2010WO2010077971A3 Acne treatment powder foundation
11/04/2010WO2010077310A3 Amide derivatives of ethacrynic acid
11/04/2010WO2010077061A3 Pharmaceutical formulations containing antiviral drugs
11/04/2010WO2010076566A3 Indoles useful in the treatment of inflammation
11/04/2010WO2010075558A3 Compositions and methods for inhibition of the jak pathway
11/04/2010WO2010075444A3 Nasal formulations of metoclopramide
11/04/2010WO2010075286A8 MOLECULAR ACTIVATORS OF THE Wnt/β-CATENIN PATHWAY
11/04/2010WO2010075101A3 Treating picornavirus infection by targeting microrna mir-141
11/04/2010WO2010068863A3 Pyrimidine compounds and methods of making and using same
11/04/2010WO2010068287A3 Small molecule modulators of hepatocyte growth factor (scatter factor) activity
11/04/2010WO2010061208A3 Combination comprising a quinazoline derivative and a taxane
11/04/2010WO2010052466A3 Pharmaceutical aerosol composition
11/04/2010WO2010028173A3 Method of treating atrial fibrillation
11/04/2010WO2010017403A9 Therapeutic compositions, devices and methods for observing treated tissues
11/04/2010WO2010004386A3 Amorphous bupropion hydrobromide and preparation thereof
11/04/2010WO2010002877A3 Bycyclic nucleosides and nucleotides as therapeutic agents
11/04/2010WO2009148279A9 Triterpenoid-based compound used as a virus inhibitor
11/04/2010WO2009141142A8 Nanoparticles functionalized with sulfated amino alcohols for the inhibition of selectin-mediated cell adhesion
11/04/2010WO2009137081A3 Small molecule inhibitors of plasmodium falciparum dihydroorotate dehydrogenase
11/04/2010WO2009121997A3 Pegylated nanoparticles containing a biologically active molecule and use thereof
11/04/2010WO2009120919A3 Fenofibrate dosage forms
11/04/2010WO2009117080A8 Quinazoline derivatives as raf kinase modulators and methods of use thereof
11/04/2010WO2008148747A8 Pdz domain modulators
11/04/2010US20100281585 Composition and method for increasing resistance against plant pathogen by comprising bacterial genetic materials, and plant produced by the method
11/04/2010US20100281547 Selecting animals for desired genotypic or potential phenotypic properties
11/04/2010US20100280452 Medical devices having multiple layers
11/04/2010US20100280249 Synthesis of 4-amino-thalidomide enantiomers
11/04/2010US20100280232 Multicomponent assemblies having enhanced binding properties for diagnosis and therapy
11/04/2010US20100280177 Multicomponent assemblies having enhanced binding properties for diagnosis and therapy
11/04/2010US20100280132 Method for modifying polyphenol containing plant materials and medical uses of modified polyphenol plant containing materials
11/04/2010US20100280131 Methods for the inhibition of atrophy or for treatment or prevention of atrophy-related symptoms in women
11/04/2010US20100280130 Quinone derivative 2,3-dimethoxy-5-methyl-6-(10-hydroxydecyl)-1,4-benzoquinone for the treatment of primary progressive multiple sclerosis
11/04/2010US20100280129 Method of Treating Pain Caused by Inflammation
11/04/2010US20100280128 Use of 1-phenyl-3-dimethylaminopropane Compounds for Treating Rheumatoid Pain
11/04/2010US20100280127 Inhibiting neurotransmitter reuptake
11/04/2010US20100280126 Method of Inhibiting Inflammatory Pain
11/04/2010US20100280125 Medicinal agent
11/04/2010US20100280124 Acyl-urea derivatives and uses thereof
11/04/2010US20100280123 Food supplement containing alpha-keto acids for supporting diabetes therapy
11/04/2010US20100280122 Transdermal delivery of beneficial substances effected by a hostile biophysical environment
11/04/2010US20100280121 Production of adapalene gels
11/04/2010US20100280120 Compound inducing angiogenesis response in ischaemic tissues
11/04/2010US20100280119 L-ornithine phenyl acetate and methods of making thereof
11/04/2010US20100280118 Methods for treating substance dependence
11/04/2010US20100280117 Menorrhagia Instrument and Method for the Treatment of Menstrual Bleeding Disorders
11/04/2010US20100280116 Linoleic acid active agents for enhancing probability of becoming pregnant
11/04/2010US20100280115 Compositions of human lipids and methods of making and using same
11/04/2010US20100280113 Compositions and methods for the treatment of cystic fibrosis
11/04/2010US20100280112 Composition Enriched in Diglyceride with Conjugated Linoleic Acid
11/04/2010US20100280111 Skin external preparations and cosmetics
11/04/2010US20100280110 (3r)-l-menthyl 3-hydroxybutyrate, process for producing the same, and sensate composition comprising the same
1 ... 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 2034 2035 2036 2037 2038 ... 7860